Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual mirror therapy shows promise for rare pain condition

NCT ID NCT05787119

Symptom relief Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding augmented reality mirror therapy (ARMT) to standard physical and occupational therapy helps people with complex regional pain syndrome (CRPS) of the upper limb. Seven participants received both conventional therapy and ARMT sessions over a month. Researchers measured changes in hand function, pain severity, and quality of life to see if ARMT provides extra benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
augmented reality mirror therapy
What this could lead to
If it works, this could offer a new, non-drug way to ease pain and improve hand movement for people with complex regional pain syndrome.
What could go wrong
This was a very small study with only 7 people, so results may not apply to everyone. The therapy is still experimental and needs larger trials to confirm benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7 people

The number who actually took part.

Started

Sep 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Patient with CRPS of the upper limb according to the Budapest criteria. * Patient newly treated at the Centre d'Evaluation et de Traitement de la Douleur of the CHU of Nîmes. * Patient with a diagnosis of CRPS for more than 3 months Exclusion Criteria: * The subject is participating in a therapeutic study, or is in a period of exclusion determined by a previous study * The subject unable to express consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Patient is pregnant, parturient or breastfeeding * Patient with medically significant visual impairment that is incompatible with the practice of ARMT * Patient with CRPS secondary to a stroke * Patient with cognitive disorders (Montreal Cognitive Assessment scale less than 26) * Patient with Unilateral Spatial Negligence according to the Bell's test * Patient with arthrodesis of one of the joints of the upper limbs. * Patient with an unhealed fracture of one of the upper limbs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complex regional pain syndromes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

complex regional pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Complex regional pain syndromes

Contacts and locations

Locations

  • CHU de Nîmes

    Nîmes, 30129, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.